NCT02579057View on ClinicalTrials.gov

Sub-Q Versus IV Furosemide in Acute Heart Failure

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

July 31, 2017

Conditions
Congestive Heart Failure
Interventions
DRUG

Furosemide Injection Solution (SCP-101)

DRUG

Furosemide Injection Solution, USP

Trial Locations (1)

21287

Johns Hopkins Hospital Heart Failure Bridge Clinic, Baltimore

All Listed Sponsors
collaborator

scPharmaceuticals, Inc.

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT02579057 - Sub-Q Versus IV Furosemide in Acute Heart Failure | Biotech Hunter | Biotech Hunter